Document Detail

Multicentric reticulohistiocytosis: case report with response to infliximab and review of treatment options.
MedLine Citation:
PMID:  24733253     Owner:  NLM     Status:  Publisher    
Multicentric reticulohistiocytosis (MRH) is a rare systemic and devastating disease with main involvement of skin and joints, frequently related with malignancies. Macrophages and TNFα are the main targets of multiple treatment options with variable results. Although MRH has the tendency of self-resolve in an average of 8 years, treatment must be started early to avoid sequelae, mainly in joints with severe deformities and daily life activity impairment. We describe a 50-year-old man with skin and joint involvement, with a non-previously described muscle affectation, that failed to different drugs and achieved skin improvement with infliximab. We review for the first time in medical literature the available therapeutic options of MRH and its outcomes and propose possible future targets.
Cristina C Macía-Villa; Antonio Zea-Mendoza
Related Documents :
17822903 - Gait pattern normalization after lateral retinaculum reconstruction for iatrogenic medi...
21061013 - State-of-the-art of bone marrow analysis in forensic toxicology: a review.
23022893 - Remote cerebellar hemorrhage in neurosurgery.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-4-15
Journal Detail:
Title:  Clinical rheumatology     Volume:  -     ISSN:  1434-9949     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-4-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its d...
Next Document:  Convergent routes to substituted naphthylamides.